Predicted protein targets (top 9)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CDC25A | P30304 | 7/20 | 0.59 |
| ▸ | CDC25B | P30305 | 7/20 | 0.59 |
| ▸ | CDC25C | P30307 | 6/20 | 0.59 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.51 |
| ▸ | MAPT | P10636 | 1/20 | 0.51 |
| ▸ | THRB | P10828 | 1/20 | 0.51 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.51 |
| ▸ | TYMP | P19971 | 2/20 | 0.40 |
| ▸ | ALOX5 | P09917 | 4/20 | 0.39 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL6238660 | 1.00 | CDC25A (0.59) | CDC25ACDC25BCDC25CALDH1A1MAPT | |
| SCHEMBL6238772 | 1.00 | CDC25A (0.59) | CDC25ACDC25BCDC25CALDH1A1MAPT | |
| SCHEMBL6237311 | 1.00 | CDC25A (0.59) | CDC25ACDC25BCDC25CALDH1A1MAPT | |
| SCHEMBL10908238 | 1.00 | CDC25A (0.59) | CDC25ACDC25BCDC25CALDH1A1MAPT | |
| SCHEMBL10663018 | 1.00 | CDC25A (0.59) | CDC25ACDC25BCDC25CALDH1A1MAPT | |
| SCHEMBL23581852 | 0.98 | CDC25A (0.56) | CDC25ACDC25BCDC25CALDH1A1MAPT | |
| SCHEMBL8944601 | 0.92 | CDC25A (0.49) | CDC25ACDC25BCDC25CALDH1A1MAPT | |
| SCHEMBL1165248 | 0.92 | CDC25A (0.47) | CDC25ACDC25BCDC25CALDH1A1MAPT | |
| SCHEMBL9188758 | 0.90 | CDC25A (0.65) | CDC25ACDC25BCDC25CALDH1A1MAPT | |
| SCHEMBL17122005 | 0.88 | CDC25A (0.68) | CDC25ACDC25BCDC25CALDH1A1MAPT |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-6590071-B1 | Increasing the delivery of hydrophilic amine containing compounds to the cell having a mucosal barrier, in which a compound of given formula penetrates the mucosal barrier of the cell; free amine is liberated by hydrolysis | UNIVERSITY OF SOUTHERN CALIFORNIA | 2003-07-08 | — | — | US | disclosed |